Literature DB >> 27125352

From melanocytes to melanomas.

A Hunter Shain1, Boris C Bastian1.   

Abstract

Melanomas on sun-exposed skin are heterogeneous tumours, which can be subtyped on the basis of their cumulative levels of exposure to ultraviolet (UV) radiation. A melanocytic neoplasm can also be staged by how far it has progressed, ranging from a benign neoplasm, such as a naevus, to a malignant neoplasm, such as a metastatic melanoma. Each subtype of melanoma can evolve through distinct evolutionary trajectories, passing through (or sometimes skipping over) various stages of transformation. This Review delineates several of the more common progression trajectories that occur in the patient setting and proposes models for tumour evolution that integrate genetic, histopathological, clinical and biological insights from the melanoma literature.

Entities:  

Mesh:

Year:  2016        PMID: 27125352     DOI: 10.1038/nrc.2016.37

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  162 in total

1.  Pseudomelanoma: recurrent melanocytic nevus following partial surgical removal.

Authors:  R Kornberg; A B Ackerman
Journal:  Arch Dermatol       Date:  1975-12

2.  Proliferation marker Ki-S5 as a diagnostic tool in melanocytic lesions.

Authors:  P Rudolph; C Schubert; B Schubert; R Parwaresch
Journal:  J Am Acad Dermatol       Date:  1997-08       Impact factor: 11.527

Review 3.  NIH Consensus conference. Diagnosis and treatment of early melanoma.

Authors: 
Journal:  JAMA       Date:  1992-09-09       Impact factor: 56.272

4.  Risk factors for lentigo maligna melanoma compared with superficial spreading melanoma: a case-control study in Australia.

Authors:  Marina Kvaskoff; Victor Siskind; Adèle C Green
Journal:  Arch Dermatol       Date:  2011-10-17

5.  Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma.

Authors:  Vikas K Goel; Alexander J F Lazar; Carla L Warneke; Mark S Redston; Frank G Haluska
Journal:  J Invest Dermatol       Date:  2006-01       Impact factor: 8.551

6.  IRF4 variants have age-specific effects on nevus count and predispose to melanoma.

Authors:  David L Duffy; Mark M Iles; Dan Glass; Gu Zhu; Jennifer H Barrett; Veronica Höiom; Zhen Z Zhao; Richard A Sturm; Nicole Soranzo; Chris Hammond; Marina Kvaskoff; David C Whiteman; Massimo Mangino; Johan Hansson; Julia A Newton-Bishop; Veronique Bataille; Nicholas K Hayward; Nicholas G Martin; D Timothy Bishop; Timothy D Spector; Grant W Montgomery
Journal:  Am J Hum Genet       Date:  2010-06-17       Impact factor: 11.025

Review 7.  Anatomy, histology and immunohistochemistry of normal human skin.

Authors:  Jean Kanitakis
Journal:  Eur J Dermatol       Date:  2002 Jul-Aug       Impact factor: 3.328

8.  A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families.

Authors:  Margaret A Tucker; Mary C Fraser; Alisa M Goldstein; Jeffery P Struewing; Mary A King; John T Crawford; Ellen A Chiazze; Deborah P Zametkin; Laura S Fontaine; Wallace H Clark
Journal:  Cancer       Date:  2002-06-15       Impact factor: 6.860

9.  Mutations of the BRAF gene in benign and malignant melanocytic lesions.

Authors:  Amir S Yazdi; Gabriele Palmedo; Michael J Flaig; Ursula Puchta; Andrea Reckwerth; Arno Rütten; Thomas Mentzel; Heino Hügel; Markus Hantschke; Monika-Hildegard Schmid-Wendtner; Heinz Kutzner; Christian A Sander
Journal:  J Invest Dermatol       Date:  2003-11       Impact factor: 8.551

10.  Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study.

Authors:  H Kitchener; A M C Swart; Q Qian; C Amos; M K B Parmar
Journal:  Lancet       Date:  2008-12-16       Impact factor: 79.321

View more
  205 in total

Review 1.  Cell-state dynamics and therapeutic resistance in melanoma from the perspective of MITF and IFNγ pathways.

Authors:  Xue Bai; David E Fisher; Keith T Flaherty
Journal:  Nat Rev Clin Oncol       Date:  2019-09       Impact factor: 66.675

Review 2.  Mitochondrial dynamics as regulators of cancer biology.

Authors:  Andrew Paul Trotta; Jerry Edward Chipuk
Journal:  Cell Mol Life Sci       Date:  2017-01-12       Impact factor: 9.261

3.  Androgen receptor functions as transcriptional repressor of cancer-associated fibroblast activation.

Authors:  Andrea Clocchiatti; Soumitra Ghosh; Maria-Giuseppina Procopio; Luigi Mazzeo; Pino Bordignon; Paola Ostano; Sandro Goruppi; Giulia Bottoni; Atul Katarkar; Mitchell Levesque; Peter Kölblinger; Reinhard Dummer; Victor Neel; Berna C Özdemir; G Paolo Dotto
Journal:  J Clin Invest       Date:  2018-11-05       Impact factor: 14.808

4.  TYRP1 mRNA goes fishing for miRNAs in melanoma.

Authors:  Maria S Soengas; Eva Hernando
Journal:  Nat Cell Biol       Date:  2017-10-31       Impact factor: 28.824

5.  From Proteomic Mapping to Invasion-Metastasis-Cascade Systemic Biomarkering and Targeted Drugging of Mutant BRAF-Dependent Human Cutaneous Melanomagenesis.

Authors:  Aikaterini F Giannopoulou; Athanassios D Velentzas; Athanasios K Anagnostopoulos; Adamantia Agalou; Nikos C Papandreou; Stamatia A Katarachia; Dimitra G Koumoundourou; Eumorphia G Konstantakou; Vasiliki I Pantazopoulou; Anastasios Delis; Maria T Michailidi; Dimitrios Valakos; Dimitris Chatzopoulos; Popi Syntichaki; Vassiliki A Iconomidou; Ourania E Tsitsilonis; Issidora S Papassideri; Gerassimos E Voutsinas; Polydefkis Hatzopoulos; Dimitris Thanos; Dimitris Beis; Ema Anastasiadou; George Th Tsangaris; Dimitrios J Stravopodis
Journal:  Cancers (Basel)       Date:  2021-04-22       Impact factor: 6.639

6.  Translation regulation in skin cancer from a tRNA point of view.

Authors:  Katerina Grafanaki; Dimitrios Anastasakis; George Kyriakopoulos; Ilias Skeparnias; Sophia Georgiou; Constantinos Stathopoulos
Journal:  Epigenomics       Date:  2018-12-19       Impact factor: 4.778

7.  H3K27me3-mediated PGC1α gene silencing promotes melanoma invasion through WNT5A and YAP.

Authors:  Chi Luo; Eduardo Balsa; Elizabeth A Perry; Jiaxin Liang; Clint D Tavares; Francisca Vazquez; Hans R Widlund; Pere Puigserver
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

8.  PET Imaging of Melanoma Using Melanin-Targeted Probe.

Authors:  Xiaowei Ma; Zhen Cheng
Journal:  Methods Mol Biol       Date:  2021

9.  MicroRNA-211 Loss Promotes Metabolic Vulnerability and BRAF Inhibitor Sensitivity in Melanoma.

Authors:  Anupama Sahoo; Sanjaya K Sahoo; Piyush Joshi; Bongyong Lee; Ranjan J Perera
Journal:  J Invest Dermatol       Date:  2018-08-01       Impact factor: 8.551

Review 10.  Why target the tumor stroma in melanoma?

Authors:  James Hutchenreuther; Andrew Leask
Journal:  J Cell Commun Signal       Date:  2017-11-06       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.